BioSpace News Archive

Policy

RM LAW Announces Class Action Lawsuit Against AVEO Pharmaceuticals, Inc.

RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased AVEO Pharmaceuticals, Inc. between August 4, 2016 and January 31, 2019, inclusive.

March 5, 2019
·
3 min read
Business

Canopy Health Announces Jeff Burnich, M.D., as Chief Physician Enterprise Executive

Canopy Health is excited about the positive contributions Dr. Burnich will bring to the organization for its continued growth.

March 5, 2019
·
4 min read
Business

Cathy Barr Joins Pelvital USA, Inc. Board of Directors

Pelvital USA, Inc. announces that Cathy Barr has joined its Board of Directors.

March 5, 2019
·
2 min read
FDA

FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor’s office or clinic

The U.S. Food and Drug Administration approved Spravato nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried other antidepressant medicines but have not benefited from them.

March 5, 2019
·
5 min read
FDA

Janssen Announces U.S. FDA Approval of SPRAVATO™ (esketamine) CIII Nasal Spray for Adults with Treatment-Resistant Depression (TRD) Who Have Cycled Through Multiple Treatments Without Relief

To support responsible use of the medication while ensuring patient access, SPRAVATO™ will launch with a controlled distribution model, including a comprehensive Risk Evaluation and Mitigation Strategy

March 5, 2019
·
17 min read
Deals

Invitae Announces Pricing of Public Offering of Common Stock - March 5, 2019

Invitae Corporation announced the pricing of an underwritten public offering of 9,000,000 shares of its common stock at a price to the public of $19.00 per share.

March 5, 2019
·
3 min read
Business

Surgical Theater Welcomes Former Chairman and CEO of Medtronic to Advisory Board

William Hawkins to help accelerate growth within the healthcare communities of patients, surgeons and hospitals

March 5, 2019
·
3 min read
FDA

Houston based depression psychiatrist, Dr. Sandhya Prashad, M.D., tells how this new drug might save lives and cost less than expected

FDA approves Spravato, a version of ketamine backed by Johnson & Johnson that sees rapid results in patients battling treatment resistant depression and suicide

March 5, 2019
·
3 min read
Business

Stem Cell Transplant Potentially “Cures” Second HIV Patient

Although cautious about using the word “cure,” researchers have described a second person globally to be cleared of HIV, the virus that causes AIDS. The new patient, who remains unnamed, is dubbed the “London Patient.”

March 5, 2019
·
3 min read
·
Mark Terry
Deals

Could Purdue Pharma File for Bankruptcy as a Legal Maneuver to Address Lawsuits?

As Purdue Pharma grapples with multiple lawsuits over its OxyContin pain killer, there are reports that the drugmaker is exploring bankruptcy as a legal defense mechanism.

March 5, 2019
·
3 min read
·
Alex Keown